The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat

doi:10.1016/0041-008X(88)90232-3

Toxicology and Applied Pharmacology

Volume 92, Issue 1, January 1988, Pages 103-112

https://doi.org/10.1016/0041-008X(88)90232-3 Get rights and content

Abstract

Fischer 344 rats and B6C3F1 mice of both sexes were exposed to 400 ppm perchloroethylene (PER) by inhalation, 6 hr/day for 14, 21, or 28 days or to 200 ppm for 28 days. Increased numbers of peroxisomes were seen under the electron microscope and increased peroxisomal cyanide-insensitive palmitoyl CoA oxidation was measured (3.6-fold increase in males and 2.1-fold increase in females) in the livers of mice exposed to PER. Hepatic catalase was not increased. Peroxisome proliferation was not observed in rat liver or in the kidneys of either species. Trichloroacetic acid (TCA), a known carcinogen and hepatic peroxisome proliferating agent, was found to be a major metabolite of PER. Blood levels of this metabolite measured in mice and rats during and for 48 hr after a single 6-hr exposure to 400 ppm PER showed that peak blood levels in mice were 13 times higher than those seen in rats. Comparison of areas under the curves over the time course of the experiment showed that mice were exposed to 6.7 times more TCA than rats. The difference in metabolism of PER to TCA in mice and rats leads to the species difference in hepatic peroxisome proliferation which is believed to be the basis of the species difference in hepatocarcinogenicity. Peroxisome proliferation does not appear to play a role in the apparent carcinogenicity of PER in the rat kidney.

References (38)

R.F. Beers et al.
A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase
J. Biol. Chem
(1952)
G. Bonse et al.
Chemical reactivity, metabolic oxirane formation and biological reactivity of chlorinated ethylenes in the isolated perfused rat liver preparation
Biochem. Pharmacol
(1975)
M. Bronfman et al.
Fatty acid oxidation by human liver peroxisomes
Biochem. Biophys. Res. Commun
(1979)
G. Bronzetti et al.
Genetic and biochemical studies on perchloroethylene “in vitro” and “in vivo”
Mutat. Res
(1983)
A.J. Cohen et al.
Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man
Food Cosmet. Toxicol
(1981)
J.W. Daniel
The metabolism of ³⁶Cl-labeled trichloroethylene and tetrachloroethylene in the rat
Biochem. Pharmacol
(1963)
C.R. Elcombe et al.
Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: Possible relevance to species differences in hepatocarcinogenicity
Toxicol. Appl. Pharmacol
(1985)
T.L. Goldsworthy et al.
Chlorinated hydrocarbon induced peroxisome enzyme activity in relation to species and organ carcinogenicity
Toxicol. Appl. Pharmacol
(1987)
T. Green et al.
Species differences in response to trichloroethylene. II. Biotransformation in rats and mice
Toxicol. Appl. Pharmacol
(1985)
R.J. Laib et al.
Alkylation of RNA by vinyl chloride metabolites in vitro and in vivo: Formation of 1-⁶N-etheno-adenosine
Toxicology
(1977)

O.H. Lowry et al.

Protein measurement with the Folin phenol reagent

J. Biol. Chem

(1951)

M.S. Prout et al.

Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice

Toxicol. Appl. Pharmacol

(1985)

D. Reichert

Biological actions and interactions of tetrachloroethylene

Mutat. Res

(1983)

R.H. Reitz et al.

Effects of vinylidene chloride on DNA synthesis and DNA repair in the rat and mouse: A comparative study with dimethylnitrosamine

Toxicol. Appl. Pharmacol

(1980)

A.M. Schumann et al.

The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity

Toxicol. Appl. Pharmacol

(1980)

H. Bartsch et al.

Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadiene and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450 linked microsomal mono-oxygenases

Arch. Toxicol

(1979)

M.E. Beard et al.

Distribution of peroxisomes (microbodies in the nephron of the rat. A cytochemical study)

J. Cell Biol

(1969)

W. Dekant et al.

Absorption elimination and metabolism of tetrachloroethylene

Naunyn-Schmiedeberg's Arch. Pharmacol. (Suppl.)

(1985)

J.E. Doe et al.

Novel chambers for long term inhalation studies

Cited by (68)

Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice
2018, Toxicology and Applied Pharmacology
Citation Excerpt :
In vivo data for B6C3F1 and SW strains were reviewed thoroughly and used in the previous perc PBPK model (Chiu and Ginsberg, 2011). Studies in B6C3F1 mice included inhalation, closed chamber and oil gavage administration at a range of exposure levels, and reported perc and its oxidative metabolite, TCA, in blood (Gargas, 1988; Odum et al., 1988; Gearhart et al., 1993; Reitz et al., 1996). Only data using aqueous gavage of perc was available for the SW strain, reporting concentrations of perc in blood, liver and kidney, and its oxidative metabolite, TCA, in blood and liver (Philip et al., 2007).
Perchloroethylene (perc) induced target organ toxicity has been associated with tissue-specific metabolic pathways. Previous physiologically-based pharmacokinetic (PBPK) modeling of perc accurately predicted oxidative metabolites but suggested the need to better characterize glutathione (GSH) conjugation as well as toxicokinetic uncertainty and variability.
We updated the previously published “harmonized” perc PBPK model in mice to better characterize GSH conjugation metabolism as well as the uncertainty and variability of perc toxicokinetics.
The updated PBPK model includes expanded models for perc and its oxidative metabolite trichloroacetic acid (TCA), and physiologically-based sub-models for conjugative metabolites. Previously compiled mouse kinetic data in B6C3F1 and Swiss-Webster mice were augmented to include data from a recent study in male C57BL/6J mice that measured perc and metabolites in serum and multiple tissues. Hierarchical Bayesian population analysis using Markov chain Monte Carlo was conducted to characterize uncertainty and inter-strain variability in perc metabolism.
The updated model fit the data as well or better than the previously published “harmonized” PBPK model. Tissue dosimetry for both oxidative and conjugative metabolites was successfully predicted across the three strains of mice, with estimated residuals errors of 2-fold for majority of data. Inter-strain variability across three strains was evident for oxidative metabolism; GSH conjugation data were only available for one strain.
This updated PBPK model fills a critical data gap in quantitative risk assessment by predicting the internal dosimetry of perc and its oxidative and GSH conjugation metabolites and lays the groundwork for future studies to better characterize toxicokinetic variability.
Trichloroethylene-induced formic aciduria: Effect of dose, sex and strain of rat
2013, Toxicology
Citation Excerpt :
So at this stage we cannot rule out that a strain difference in the production of TCE-OH and or TCA could explain the strain difference in formic aciduria. Interestingly, PCE which like TCE undergoes metabolism to generate TCA (Odum et al., 1988) showed little evidence of formic aciduria after 3 daily doses 16 mg/kg (Fig. 5). Other chlorinated solvents at higher doses also caused formic aciduria, namely carbon tetrachloride and chloroform (Fig. 5) and bromdichloromethane (Lock et al., 2004).
The industrial solvent trichloroethylene (TCE) has been reported to increase the excretion of formic acid in the urine of male Fischer 344 (F-344) rats following large oral doses. We have examined the dose–response relationship for formic aciduria in male and female Fischer 344 rats, the effect of some known metabolites of TCE and examined the response in male Wistar rats to help understand its relevance to renal toxicity. We report that doses of TCE as low as 8 mg/kg for 3 days to both male and female F344 rats produced formic aciduria. The formic aciduria was time-dependent being more marked after 3 doses compared to one dose in male F344 rats and to a lesser extent in female F344 rats. TCE administration to male Wistar rats produced less formic aciduria than in male F344 rats, indicating a strain difference in response. As TCE is primarily metabolised by cytochrome P450 2E1, Wistar rats were administered inducers of cytochrome P450 2E1 followed by TCE, this increased formic acid excretion to a concentration similar to that observed in male F344 rats, indicating a role for P450. Administration of the major metabolites of TCE, trichloroethanol and trichloroacetic acid to male F344 rats also produced a marked and sustained formic aciduria, while the metabolite of TCE formed via glutathione conjugation had no effect on formic acid excretion. The mechanism whereby this response occurs is currently not understood, but the formic acid excreted is not a metabolite of TCE, but appears to be due to interference with the metabolic utilisation of formate by a down stream metabolite of TCE. Over the three days of the studies no histopathological evidence of kidney toxicity was observed in F344 rats given TCE, indicating that the perturbation of formate metabolism does not lead to acute renal injury.
Development and evaluation of a harmonized physiologically based pharmacokinetic (PBPK) model for perchloroethylene toxicokinetics in mice, rats, and humans
2011, Toxicology and Applied Pharmacology
This article reports on the development of a “harmonized” PBPK model for the toxicokinetics of perchloroethylene (tetrachloroethylene or perc) in mice, rats, and humans that includes both oxidation and glutathione (GSH) conjugation of perc, the internal kinetics of the oxidative metabolite trichloroacetic acid (TCA), and the urinary excretion kinetics of the GSH conjugation metabolites N-Acetylated trichlorovinyl cysteine and dichloroacetic acid. The model utilizes a wider range of in vitro and in vivo data than any previous analysis alone, with in vitro data used for initial, or “baseline,” parameter estimates, and in vivo datasets separated into those used for “calibration” and those used for “evaluation.” Parameter calibration utilizes a limited Bayesian analysis involving flat priors and making inferences only using posterior modes obtained via Markov chain Monte Carlo (MCMC). As expected, the major route of elimination of absorbed perc is predicted to be exhalation as parent compound, with metabolism accounting for less than 20% of intake except in the case of mice exposed orally, in which metabolism is predicted to be slightly over 50% at lower exposures. In all three species, the concentration of perc in blood, the extent of perc oxidation, and the amount of TCA production is well-estimated, with residual uncertainties of ~ 2-fold. However, the resulting range of estimates for the amount of GSH conjugation is quite wide in humans (~ 3000-fold) and mice (~ 60-fold). While even high-end estimates of GSH conjugation in mice are lower than estimates of oxidation, in humans the estimated rates range from much lower to much higher than rates for perc oxidation. It is unclear to what extent this range reflects uncertainty, variability, or a combination. Importantly, by separating total perc metabolism into separate oxidative and conjugative pathways, an approach also recommended in a recent National Research Council review, this analysis reconciles the disparity between those previously published PBPK models that concluded low perc metabolism in humans and those that predicted high perc metabolism in humans. In essence, both conclusions are consistent with the data if augmented with some additional qualifications: in humans, oxidative metabolism is low, while GSH conjugation metabolism may be high or low, with uncertainty and/or interindividual variability spanning three orders of magnitude. More direct data on the internal kinetics of perc GSH conjugation, such as trichlorovinyl glutathione or tricholorvinyl cysteine in blood and/or tissues, would be needed to better characterize the uncertainty and variability in GSH conjugation in humans.
Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice
2007, Toxicology
The aim was to study the subchronic toxicity of perchloroethylene (Perc) by measuring injury and repair in liver and kidney in relation to disposition of Perc and its major metabolites. Male SW mice (25–29 g) were given three dose levels of Perc (150, 500, and 1000 mg/kg day) via aqueous gavage for 30 days. Tissue injury was measured during the dosing regimen (0, 1, 7, 14, and 30 days) and over a time course of 24–96 h after the last dose (30 days). Perc produced significant liver injury (ALT) after single day exposure to all three doses. Liver injury was mild to moderate and regressed following repeated exposure for 30 days. Subchronic Perc exposure induced neither kidney injury nor dysfunction during the entire time course as evidenced by normal renal histology and BUN. TCA was the major metabolite detected in blood, liver, and kidney. Traces of DCA were also detected in blood at initial time points after single day exposure. With single day exposure, metabolism of Perc to TCA was saturated with all three doses. AUC/dose ratio for TCA was significantly decreased with a concomitant increase in AUC/dose of Perc levels in liver and kidney after 30 days as compared to 1 day exposures, indicating inhibition of metabolism upon repeated exposure to Perc. Hepatic CYP2E1 expression and activity were unchanged indicating that CYP2E1 is not the critical enzyme inhibited. Hepatic CYP4A expression, measured as a marker of peroxisome proliferation was increased transiently only on day 7 with the high dose, but was unchanged at later time points. Liver tissue repair peaked at 7 days, with all three doses and was sustained after medium and high dose exposure for 14 days. These data indicate that subchronic Perc exposure via aqueous gavage does not induce nephrotoxicity and sustained hepatotoxicity suggesting adaptive hepatic repair mechanisms. Enzymes other than CYP2E1, involved in the metabolism of Perc may play a critical role in the metabolism of Perc upon subchronic exposure in SW mice. Liver injury decreased during repeated exposure due to inhibition of metabolism and possibly due to adaptive tissue repair mechanisms.
A review of perchloroethylene and rat mononuclear cell leukemia
2006, Regulatory Toxicology and Pharmacology
Mononuclear cell leukemia (MNCL) is an extremely common spontaneous disease of ageing F344 rats accompanied by splenomegaly, anemia, thrombocytopenia, and leukemic infiltration (initially of the spleen, liver, and lung). Rare in other rat strains, incidence in F344 rats is variable, has been increasing, and can exceed 70% in controls. MNCL cells possess natural killer (NK) cell characteristics and apparently, the neoplastic cells derive from large granular lymphocytes (LGL), hence the alternative name of LGL leukemia. LGL leukemia is uncommon in man and occurs in two forms: T-LGL leukemia which has a chronic course, and the much rarer NK-LGL leukemia. In addition to cell type, the latter resembles F344 LGL leukemia being acute in course and involving more pronounced splenomegaly and thrombocytopenia. Chemically related increases in MNCL in F344 rats have not been associated with induction of human LGL leukemia. Carcinogenicity studies of perchloroethylene (PERC) in several rat strains have shown moderate, not clearly dose-related, increases in MNCL only in F344 rats (two studies). There was no consistent decrease in latency and the incidence in the PERC treated groups is within the overall control range. As a response in a rat strain highly predisposed to developing MNCL, these results are not considered predictive for human cancer risk.
Effects of superoxide dismutase and polyclonal tumor necrosis factor-alpha antibodies on chloroacetate-induced cellular death and superoxide anion production by J774.A1 macrophages
2004, Comparative Biochemistry and Physiology - C Toxicology and Pharmacology
Dichloroacetate (DCA) and trichloroacetate (TCA) are by-products that are formed during the process of water chlorination and have been previously shown to induce superoxide anion (SA) production and cellular death when added to J774.A1 macrophage cultures. In this study, the effects of superoxide dismutase (SOD) and polyclonal tumor necrosis factor-alpha (TNF-α) antibodies on DCA- and TCA-induced SA production and cellular death have been tested on the J774.A1 macrophage cultures. TCA and DCA were added to different cultures either alone, each at a concentration of 16 mM, or in combination with SOD (2–12 units/ml), or with TNF-α antibodies (10 and 25 units/ml). Cells were incubated for 48 h, after which cellular death/viability, lactate dehydrognase (LDH) leakage by the cells, and SA production by the cells were determined. While TCA and DCA caused significant cellular toxicity, indicated by reduction in cellular viability and increases in LDH leakage and SA production, SOD addition resulted in significant reduction of the effects induced by the compounds. On the other hand, addition of TNF-α antibodies to the DCA- and TCA-treated cultures resulted in significant reduction of DCA- but not TCA-induced cellular death and SA production by the cells. Although these results suggest a significant role for SA in DCA- and TCA-induced cellular death, they may also suggest two different mechanisms for the chloroacetate-induced SA production by the cells.

View all citing articles on Scopus

View full text

The role of trichloroacetic acid and peroxisome proliferation in the differences in carcinogenicity of perchloroethylene in the mouse and rat

Abstract

J. Biol. Chem

Biochem. Pharmacol

Biochem. Biophys. Res. Commun

Mutat. Res

Food Cosmet. Toxicol

Biochem. Pharmacol

Toxicol. Appl. Pharmacol

Toxicol. Appl. Pharmacol

Toxicol. Appl. Pharmacol

Toxicology

J. Biol. Chem

Toxicol. Appl. Pharmacol

Mutat. Res

Toxicol. Appl. Pharmacol

Toxicol. Appl. Pharmacol

Mutagenic and alkylating metabolites of halo-ethylenes, chlorobutadiene and dichlorobutenes produced by rodent or human liver tissues. Evidence for oxirane formation by P450 linked microsomal mono-oxygenases

Arch. Toxicol

Distribution of peroxisomes (microbodies in the nephron of the rat. A cytochemical study)

J. Cell Biol

Absorption elimination and metabolism of tetrachloroethylene

Naunyn-Schmiedeberg's Arch. Pharmacol. (Suppl.)

Novel chambers for long term inhalation studies